National Institute of Allergies and Infectious Diseases head Anthony Fauci has released the results of a study which suggests that new HIV drugs from Merck and Roche may “cure” HIV in patients who have very low levels of the virus, provided those patients have already been treated “early and faithfully” with over 7 years of combination drug therapy. Patients are being lined up for a new study in which they will be “aggressively dosed” with the new meds. If the virus disappears, treatment will stop and the patients will be tracked closely for any recurrence. Fauci’s study will be published in the June 15 issue of the Journal of Infectious Disease. The stock prices of Merck and Roche have risen on this news.